Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
Telemedical Training in a Daily Perspective for Chronically Ill COPD Patients: a Cross Sectoral Study
Verified date | August 2016 |
Source | Odense University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: National Board of Health |
Study type | Interventional |
Problem:
Training is an important part of the treatment and rehabilitation of patients with chronic
obstructive pulmonary disease (COPD) because training can increase the patient's muscle
mass, lead to higher physical performance, reduce difficulties in breathing and hereby
increase the patients' capacity to make use of the medical treatment.
Rehabilitation is provided by hospitals training centres/outpatient clinics. However, the
transport is too tiring for the patients, which is why they decline taking part in it. This
can mean a worsening of their condition and an increase in readmissions.
Solution:
- To develop a better treatment for patients with severe COPD: Telemedical training of
patients with COPD in teams.
- To develop a cross-sectoral practice for the telemedical training patients will use,
thus decreasing the readmissions of OUH's patients with severe COPD
- To optimize the patient's journey in and across sector borders by using Lean methods.
Perspective:
The study is expected to contribute to improving treatment of severely ill patients with
COPD cross-sectorally. The results are expected to contribute to reducing readmissions and
raising the level of evidence in telemedical research on training patients with severe COPD.
The study's findings may be of use in relation to other patient groups who have difficulties
coming to training.
Background:
This research project has its starting point in a pilot project. Its goal was to determine
whether severely ill COPD patients could train at home and earlier than normal. Evaluation
showed patients found it reassuring to train with the help of the COPD briefcase. They found
it increased their physical and mental well-being.
Method:
To gain knowledge of the effect of telemedical training. The patient's strength, daily
activity level and quality of life will be measured by conducting a randomized controlled
trial including 125 patients - 62 in the intervention group and 62 in the control group.
Qualitative research methods will be used to explore the user perspective concerning
patients, family and health professionals. The method is critical psychological practice
research.
A Lean method consultant from University Hospital Odense (OUH) will be involved in
developing the best clinical pathway for the patients and the professionals.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | August 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients with severe and very severe COPD, that is FEV1/FVC under 0,7, FEV1 under 50 % of the expected value and grade three and above on the Medical Research Council Dyspnoea Scale (MRC- Dyspnoea Scale). - The patients have rejected OUH's offer of training at the hospital. - The patients must be mobile enough to complete the training. - The patients are motivated to participate in individual adjusted telemedical training in teams. - The patients have at the same time been offered Telemedical consultations by a nurse - The patients biggest problem concerning physical activity has to be their shortness of breath - The patients live in either Svendborg or Odense Exclusion Criteria: - patients with lacking ability to communicate via telephone and/or computer screen, severe kidney insufficiency or cardiac insufficiency, saturation less than 88 % and possibly malignant changes in lung(s). |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital | CoLab Denmark, Danish Lung Association, Region of Southern Denmark, TREFOR, University of Southern Denmark |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Participation in municipial or private training | We are interested in knowing whether the patients in the intervention or control group participate in (other) training. there are no questionaire connected to this question, we simply ask the patients. | 3 and 7 weeks, 3 and 6 months | No |
Other | The total cost of treatment compared with effectiveness | The cost-effective analysis estimates the total cost of the intervention (equipment and use of staff per patient) and the economic advantages such as a decline in readmissions. The total net costs are compared to the clinical changes. | 7 weeks,3 and 6 months | No |
Other | System Usability Scale (SUS) | A questionaire used in economic evaluation for estimating the satisfaction and safety of the users of the technology | 7 weeks | No |
Primary | The Stand up - sit down five times test (FTSST) | The FTSST test (Stand up - sit down five times) is a function test, which measures lower body strength. It gives a picture of the ability to get up from a chair, which is a daily activity. The smallest relevant change is 2,7 seconds (Reuben and Siu, 1990). Whether patients continue rehabilitation training in the municipal sphere, after telemedical training is completed is also noted. | 7 weeks | No |
Secondary | The Clinical COPD Questionnaire (CCQ) | The Clinical COPD Questionnaire (CCQ) is a validated questionnaire, measuring the health status for patients with COPD by using a standardized self-administered questionnaire about COPD. CCQ is useful for comparing measurements of health status at group level. In addition for quantifying changes in health after treatment and correlating with COPD Assesment Test (CAT) and Saint George's Respiratory Questionnaire (SGRQ) | 3 and 7 weeks, 3 and 6 months | No |
Secondary | The Activities of Daily Living Questionnaire (ADL - Q) | ADL - Q is a questionnaire, completed by the patient that measures the individual's perception of their own abilities to carry out daily activities | 7 weeks, 3 and 6 months | No |
Secondary | Physical Activity Scale | The Physical Activity Scale is a validated questionnaire, completed by the patient that measures the extent of a participant's physical activity on an average 24 hour period | 3 and 7 weeks, 3 and 6 months | No |
Secondary | The Stand up - sit down five times test (FTSST) | The FTSST test (Stand up - sit down five times) is a function test, which measures lower body strength. It gives a picture of the ability to get up from a chair, which is a daily activity. The smallest relevant change is 2,7 seconds (Reuben and Siu, 1990). Whether patients continue rehabilitation training in the municipal sphere, after telemedical training is completed is also noted. | 3 weeks, 3 and 6 months | No |
Secondary | Readmissions | Whether telemedical training has an effect on readmissions for patients with COPD will be examined by comparing the number of admissions for the intervention group and the control group. Data will be requisitioned from the Region's IT. | 3 and 6 months | No |
Secondary | Walking distance | The participants will be asked if they can walk 300 meters. This has shown to be a good clinical determinants of a poor 6-min walking distance (<350 m) in patients with COPD (Spruit M. et al 2009) | 3 and 7 weeks, 3 and 6 months | No |
Secondary | European Quality of Life-5 Dimensions (EQ5D) | EQ5D is a validated questionaire, developed to estimate health status (Brooks, 1996) | 3 and 7 weeks, 3 and 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|